CAS: 625853-75-0 - (3S,4S,5S,6R)-6-[2-[6-[2-[4-[(2,4-dioxothiazolidin-5-yl)methyl]phenoxy]ethyl]-3-pyridyl]ethoxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
Fórmula:C25H28N2O10S
InChI:InChI=1/C25H28N2O10S/c28-18-19(29)21(23(32)33)37-24(20(18)30)36-9-7-14-1-4-15(26-12-14)8-10-35-16-5-2-13(3-6-16)11-17-22(31)27-25(34)38-17/h1-6,12,17-21,24,28-30H,7-11H2,(H,32,33)(H,27,31,34)/t17?,18-,19-,20-,21?,24+/m0/s1
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Hydroxy pioglitazone (M-VII) b-D-glucuronide REF: 7W-GC3051CAS: 625853-75-0 | - - - | A consultar | Qua 27 Nov 24 | |
Hydroxy Pioglitazone (M-VII) beta-D-Glucuronide REF: TR-H952065CAS: 625853-75-0 | - - - | 20.168,00 € | Ter 07 Jan 25 | |
Hydroxy pioglitazone (M-VII) b-D-glucuronide REF: 3D-MH16747CAS: 625853-75-0 | Min. 95% | A consultar | Ter 07 Jan 25 |
Ref: 7W-GC3051
Tamanho indefinido | A consultar |
Hydroxy Pioglitazone (M-VII) beta-D-Glucuronide
Produto ControladoRef: TR-H952065
75mg | 20.168,00 € |
Hydroxy pioglitazone (M-VII) b-D-glucuronide
Ref: 3D-MH16747
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |